Veracyte
VCYT
$19.89
Share price
-2.21%
Change (1 day)
-12.92%
Change (1 year)
Categories
Veracyte (VCYT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $70.8 M
According to Veracyte's latest financial reports the company's total liabilities are $70.8 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Veracyte - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $70.8 M | -12.83% |
| 2022-12-31 | $81.22 M | -11.05% |
| 2021-12-31 | $91.31 M | 154.13% |
| 2020-12-31 | $35.93 M | 0.49% |
| 2019-12-31 | $35.75 M | -12.54% |
| 2018-12-31 | $40.88 M | -1.35% |
| 2017-12-31 | $41.44 M | -0.02% |
| 2016-12-31 | $41.45 M | 72.76% |
| 2015-12-31 | $23.99 M | 2.26% |
| 2014-12-31 | $23.46 M | 1.2% |
| 2013-12-31 | $23.18 M | 63.68% |
| 2012-12-31 | $14.16 M | 637.43% |
| 2011-12-31 | $1.92 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | $3.32 B | 4,597.52% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.36 B | 413.11% | 🇺🇸 USA |
 Biocept
BIOC | $21.81 M | -69.19% | 🇺🇸 USA |